IDEAYA Biosciences, Inc. (IDYA) vs Tarsus Pharmaceuticals, Inc. (TARS)
- IDEAYA Biosciences, Inc. IDYA 32.85 −2.95%
- Tarsus Pharmaceuticals, Inc. TARS 68.07 −4.11%
IDEAYA Biosciences, Inc. and Tarsus Pharmaceuticals, Inc. are both Biotechnology companies. IDEAYA Biosciences, Inc. and Tarsus Pharmaceuticals, Inc. are of similar size ($3.5B and $3.3B). IDEAYA Biosciences, Inc. grew revenue faster over the last twelve months: 901.2% against 105.2%. Tarsus Pharmaceuticals, Inc. has the higher net margin (−7.67% vs −74.8%) and the higher return on invested capital (0.00% vs −36.7%). Across the 17 metrics below, Tarsus Pharmaceuticals, Inc. leads on 10 and IDEAYA Biosciences, Inc. on 7.
Valuation
Profitability
| Metric | IDYA | TARS | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 93.28% | 65.16% |
| Operating margin | (92.66%) | (8.00%) | 0.00% |
| Net margin | (74.75%) | (7.67%) | 0.00% |
| Free cash flow margin | (48.64%) | 9.24% | 0.00% |
| Return on equity | (16.22%) | (13.68%) | (56.36%) |
| Return on assets | (14.89%) | (8.40%) | (48.04%) |
| Return on invested capital | (36.65%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack